Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8 + T cells with limited breadth of HIV-1 inhibition

by Peter J. Hayes, Josephine H. Cox, Adam R. Coleman, Natalia Fernandez, Philip J. Bergin, Jakub T. Kopycinski, Sorachai Nitayaphan, Punnee Pitisuttihum, Mark De Souza, Ann Duerr, Cecilia Morgan, Jill W. Gilmour
Published 2018